Correlation Between RenovoRx and Capricor Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both RenovoRx and Capricor Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining RenovoRx and Capricor Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between RenovoRx and Capricor Therapeutics, you can compare the effects of market volatilities on RenovoRx and Capricor Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in RenovoRx with a short position of Capricor Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of RenovoRx and Capricor Therapeutics.

Diversification Opportunities for RenovoRx and Capricor Therapeutics

0.06
  Correlation Coefficient

Significant diversification

The 3 months correlation between RenovoRx and Capricor is 0.06. Overlapping area represents the amount of risk that can be diversified away by holding RenovoRx and Capricor Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Capricor Therapeutics and RenovoRx is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on RenovoRx are associated (or correlated) with Capricor Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Capricor Therapeutics has no effect on the direction of RenovoRx i.e., RenovoRx and Capricor Therapeutics go up and down completely randomly.

Pair Corralation between RenovoRx and Capricor Therapeutics

Given the investment horizon of 90 days RenovoRx is expected to generate 1.13 times more return on investment than Capricor Therapeutics. However, RenovoRx is 1.13 times more volatile than Capricor Therapeutics. It trades about 0.22 of its potential returns per unit of risk. Capricor Therapeutics is currently generating about -0.14 per unit of risk. If you would invest  103.00  in RenovoRx on August 30, 2024 and sell it today you would earn a total of  23.00  from holding RenovoRx or generate 22.33% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

RenovoRx  vs.  Capricor Therapeutics

 Performance 
       Timeline  
RenovoRx 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in RenovoRx are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, RenovoRx unveiled solid returns over the last few months and may actually be approaching a breakup point.
Capricor Therapeutics 

Risk-Adjusted Performance

19 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Capricor Therapeutics are ranked lower than 19 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak basic indicators, Capricor Therapeutics reported solid returns over the last few months and may actually be approaching a breakup point.

RenovoRx and Capricor Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with RenovoRx and Capricor Therapeutics

The main advantage of trading using opposite RenovoRx and Capricor Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if RenovoRx position performs unexpectedly, Capricor Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Capricor Therapeutics will offset losses from the drop in Capricor Therapeutics' long position.
The idea behind RenovoRx and Capricor Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.

Other Complementary Tools

Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Money Managers
Screen money managers from public funds and ETFs managed around the world
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios